ReleaseWire

European Point of Care Testing Market 2018: Opportunities, Sales Revenue, Emerging Trends, Competitive Landscape, Top Key Players Like Allergan Study Forecast to 2024

The major factors driving the growth of this market are the rising scope of POCT devices, advancement in technology, increasing incidence of chronic diseases, rising demand for self-testing point-of-care testing devices, decentralized laboratory testing, and technological advancements like microfluidic lab on a chip technology. These factors increase the demand for devices such as blood glucose meter, CRP, HBA1C, Homocystein. On the other hand, high costsare regulatory hurdles that may hinder the growth of the market.

Posted: Tuesday, July 31, 2018 at 2:45 AM CDT

Pune, India -- (SBWire) -- 07/31/2018 --Europe point-of-care testing market report contains an in-depth profiling of the key market players, along with the recent developments (new product developments, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their position in the market. For instance, in 2016, Health care giant Abbott Laboratories (U.S.) has acquiredAlere Inc. (U.S.), a diagnostics-testing company for USD 5.8 billion.

Request for Free Sample Report @: http://databridgemarketresearch.com/request-a-sample/?dbmr=europe-poct-device-market

Europe Point of Care Testing Market is expected to reach USD 11,682.54 billion by 2024 from USD 6,051.05 billion in 2016, at a CAGR of 8.6% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Drivers:

Some of the major factors driving the Europe POCT device market for rising scope of POCT devices, advancement in technology, increasing incidence of chronic diseases, rising demand for self-testing point-of-care testing devices, decentralized laboratory testing, and technological advancements like microfluidic lab on a chip technology. These factors increase the demand for devices such as blood glucose meter, CRP, HBA1c, homocystein.

RISING SCOPE OF POCT DEVICES

In recent times demand for POCT devices are rising due to instant test results and mobility feature. POCT devices are helping them in avoiding the delays for non-emergency patients by accessing immediate results, ultimately improving the decision making time as compared to laboratory results and traditional methods. It is easier, compatible, efficient to use and user friendly process for diagnostics

INCREASING INCIDENCE OF CHRONIC DISEASES

The prevalence of chronic diseases (such as cardiovascular diseases, hypertension, obesity, hepatitis, cancer, diabetes mellitus and many others) across the globe has increased considerably over a period of time. The rapidly increasing aging population and the subsequent rise in chronic conditions are major factors driving the demand for Europe POCT device market.

ADVANCEMENTS IN TECHNOLOGY

The Europe POCT device market is expected to show significant growth in the coming years, due to various technological advancements and new product launches in order to enhance safety and results through quick testing with reliable and noteworthy outcomeswith reduced sample volume or less blood on portable devices.

Inquire more about this report before purchase @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=europe-poct-device-market

TABLE OF CONTENTS EUROPE POINT OF CARE TESTING MARKET

1. INTRODUCTION

2. MARKET SEGMENTATION

3. MARKET OVERVIEW
3.1. DRIVERS
3.2. RESTRAINTS
3.3. OPPORTUNITIES
3.4. CHALLENGES

4. EXECUTIVE SUMMARY

5. PREMIUM INSIGHTS

6. EUROPE POINT-OF-CARE TESTING MARKET: REGULATORY SCENARIO

7. EUROPE POINT-OF-CARE TESTING MARKET: REIMBURSEMENT SCENARIO

8. EUROPE POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE

8.1. OVERVIEW

8.2. CARDIOMETABOLIC MONITORING KITS

8.2.1. CARDIAC MARKERS
8.2.2. BLOOD GAS ELECTROLYTE TESTING KITS
8.2.3. HBA1C TESTING KITS
8.2.4. LIPID TESTING KITS

8.3. INFECTIOUS DISEASE TESTING KITS

8.3.1. INFLUENZA TESTING KITS
8.3.2. HIV TESTING KITS
8.3.3. HEPATITIS TESTING KITS
8.3.4. STD TESTING KITS
8.3.5. TROPICAL DISEASESTESTING KITS
8.3.6. HEALTHCARE ASSOCIATED TESTING KITS
8.3.7. RESPIRATORY INFECTIONS TESTING KITS

8.4. CHOLESTEROL TESTING KITS

8.4.1. PROTHROMBIN TIME TESTING KITS
8.4.2. ACTIVATED CLOTTING TIME TESTING KITS

8.5. BLOOD GLUCOSE TESTING KITS

8.6. PREGNANCY AND FERTILITY TESTING KITS

8.7. TUMOR CANCER MARKERS

8.8. URINALYSIS TESTING KITS

8.9. HEMATOLOGY TESTING KITS

8.10. DRUGS OF ABUSE TESTING KITS

8.11. FECAL OCCULT TESTING KITS

8.12. RAPID COAGULATION TESTING KITS

9. EUROPE POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL

9.1. OVERVIEW
9.1.1. DIRECT TENDER
9.1.2. RETAIL PHARMACY

10. EUROPE POINT-OF-CARE TESTING MARKET, BY END USER

10.1. OVERVIEW
10.2. EUROPE POCT MARKET: HOSPITALS
10.3. EUROPE POCT MARKET: CLINICS
10.4. EUROPE POCT MARKET: AMBULATORY CARE
10.5. EUROPE POCT MARKET: HOME HEALTHCARE
10.6. EUROPE POCT MARKET: RESEARCH LABORATORIES

11. EUROPE POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE

11.1. OVERVIEW
11.2. EUROPE POCT MARKET: PRESCRIPTION BASED TESTING KITS
11.3. EUROPE POCT MARKET: OVER THE COUNTER BASED TESTING KITS

12. EUROPE POINT-OF-CARE TESTING MARKET, BY GEOGRAPHY

12.1. OVERVIEW

12.2. EUROPE POINT-OF-CARE TESTING MARKET

12.2.1. GERMANY POINT-OF-CARE TESTING MARKET
12.2.2. FRANCE POINT-OF-CARE TESTING MARKET
12.2.3. U.K. POINT-OF-CARE TESTING MARKET
12.2.4. ITALY POINT-OF-CARE TESTING MARKET
12.2.5. SPAIN POINT-OF-CARE TESTING MARKET
12.2.6. RUSSIA POINT-OF-CARE TESTING MARKET
12.2.7. TURKEY POINT-OF-CARE TESTING MARKET
12.2.8. BELGIUM POINT-OF-CARE TESTING MARKET
12.2.9. NETHERLANDS POINT-OF-CARE TESTING MARKET
12.2.10. SWITZERLAND POINT-OF-CARE TESTING MARKET
12.2.11. REST OF EUROPE POINT-OF-CARE TESTING MARKET

13. EUROPE POINT-OF-CARE TESTING MARKET : COMPANY LANDSCAPE

14. COMPANY PROFILES
14.1. JOHNSON AND JOHNSON SERVICES, INC.
14.2. BECTON, DICKINSON AND COMPANY
14.3. MEDTRONIC
14.4. F. HOFFMANN-LA ROCHE LTD
14.5. SIEMENS AG
14.6. ABBOTT
14.7. DANAHER
14.8. WERFENLIFE
14.9. HENRY SCHEIN, INC.
14.10. OPTI MEDICAL (SUBSIDIARY OF IDEXX LABORATORIES, INC)

15. RELATED REPORTS

Questions? We'll Put You On The Right Path Request Analyst Call @ https://databridgemarketresearch.com/speak-to-analyst/?dbmr=europe-poct-device-market

About Data Bridge Market Research
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com